Robert Barrow
Chief Executive Officer and Board Director
Miri Halperin Wernli, PhD
Executive President and Board Director
Cynthia Hu, JD
Chief Legal Officer & Corporate Secretary
Daniel Karlin, MD, MA
Chief Medical Officer
Schond Greenway, MBA
Chief Financial Officer
Francois Lilienthal, MD, MBA
Chief Commercial Officer
Robert Silva, PhD
VP, Head of Development
Robert Malenka, MD, PhD
Chairman of the Scientific Advisory Board, Nancy Friend Pritzker Professor in Psychiatry and Behavioral Sciences at Stanford University
Peter Bergethon, MD
Member, Scientific Advisory Board VP, Head of Quantitative & Clinical Technologies, Biogen, Inc.
Robert Dworkin, PhD
Professor of Anesthesiology and Perioperative Medicine, Neurology, and Psychiatry at University of Rochester
Maurizio Fava, MD
Psychiatrist-in-Chief of the Massachusetts General Hospital (MGH)
Maria Oquendo, MD, PhD
Ruth Meltzer Professor and Chairman of Psychiatry at University of Pennsylvania, Psychiatrist-in-Chief at the Hospital of the University of Pennsylvania
Bridget Walton, MS
VP, Global Regulatory Affairs
Kenneth Alper, MD
Clinical Associate Professor of Psychiatry and Neurology at the New York University School of Medicine
Peter Gasser, MD
Clinical Advisor
Stanley D Glick, MD PhD
Scientific Advisor
Matthew W Johnson, PhD
Clinical Advisor
Kim PC Kuypers, PhD
Scientific Collaborator & Advisor
Matthias Liechti, MD, PhD
Scientific Collaborator & Advisor
Carol Vallone
Chair of the Board of Directors, Chair of Compensation Committee, Member of Audit/Finance Committee
Natalie Wheeler, PhD
Medical Science Liaison with Dova Pharmaceuticals
John Rotrosen, MD
Professor of Psychiatry with New York University’s Langone’s Department of Psychiatry
Andreas Krebs
Vice Chair of the Board of Directors, Chair of Nomination and Governance Committee, Member of Audit/Finance Committee
Brigid Makes
Board Director, Chair of Audit/Finance Committee, Member of Compensation Committee, Member of Nomination and Governance Committee
Carrie Liao, CPA
VP, Corporate Controller & Principal Accounting Officer
Peter Mack, PhD
VP, Pharmaceutical Development
Carole Abel, MBA
VP, Programs and Portfolio Office (PPO)